List of abbreviations {#nomen0010}
=====================

AMPA

:   α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

BEC

:   blood alcohol content

BNST

:   bed nuclei of the stria terminalis

CRF

:   corticotropin-releasing factor

CSDS

:   chronic social defeat stress

CUS

:   chronic unpredictable stress

D1

:   dopamine receptor type 1

D2

:   dopamine receptor type 2

DID

:   Drinking in the Dark model of binge drinking

ELS

:   early-life stress

GABA

:   gamma-aminobutyric acid

GABA~A~

:   gamma-aminobutyric acid type A receptor

GPCR

:   G-protein coupled receptor

ILT

:   intralaminar thalamus

mAChR

:   muscarinic acetylcholine receptor

MBP

:   myelin basic protein

MDD

:   major depressive disorder

MSN

:   medium spiny neuron

mTOR

:   mammalian target of rapamycin

mTORC1

:   mammalian target of rapamycin complex 1

NAc

:   nucleus accumbens

NMDA

:   *N*-methyl-D-asparate

NPY

:   neuropeptide Y

P70S6K

:   p70 ribosomal protein S6-kinase

PFC

:   prefrontal cortex

PV

:   parvalbumin

PVT

:   paraventricular nucleus of the thalamus

REDD1

:   regulated in development and DNA damage responses 1

RT-qPCR

:   real-time quantitative polymerase chain reaction

SCVS

:   subchronic variable stress

uEPSC

:   unitary excitatory postsynaptic current

VGLUT

:   vesicular glutamate transporter

Y1R

:   neuropeptide Y type 1 receptor

1. Introduction {#sec1}
===============

Stress profoundly alters neural and behavioral development, drives changes in physiology and behavior, and contributes to increased morbidity and earlier mortality across nearly all species studied. A stressor may be any stimulus that disrupts, or is perceived to disrupt, selective homeostatic responses within the individual. Stressful stimuli can range from an attack by a predator or rival, diminished maternal care, an immune challenge, to a lack of available energy to run cellular processes (e.g. hunger) ([@bib94], [@bib122]), and organisms have a highly evolved set of responses to adapt to this wide range of challenges. The biological responses in stress adaptation involve the reallocation of metabolic resources until homeostasis can be restored, thereby enhancing the probability of survival and promoting reproductive success, the ultimate selection process driving evolutionary change.

On the one hand, moderate levels of stress exposure may well serve as catalysts for experience-dependent structural and functional changes associated with memory consolidation, behavioral regulation, and developmental processes ([@bib86], [@bib94], [@bib116], [@bib120]). However, chronic or excessively high levels of stress has been shown to have deleterious effects, impacting neural structure and functional plasticity of the brain and contributing to a variety of negative health outcomes ([@bib9], [@bib27], [@bib112], [@bib121], [@bib143], [@bib146], [@bib179]). Moreover, significant or prolonged stress early in life further increases susceptibility to morbidity and mortality, with increased risk for disease, decreased fecundity, and shortened lifespans for a variety of species, including humans ([@bib3], [@bib2], [@bib17], [@bib40], [@bib45], [@bib47], [@bib48], [@bib54], [@bib82], [@bib189]). Stress-related psychiatric disorders per se, are estimated to affect 20% of people in the United States within their lifetime, and remain a major cause of disability leading to significant social and economic costs ([@bib37], [@bib98], [@bib99], [@bib130], [@bib185]).

While elucidating the neurobiological mechanisms of vulnerability to stress-related mental disorders remains a formidable challenge, significant progress has nevertheless been made in unraveling the cellular and circuit mechanisms in a variety of experimental and pre-clinical contexts using animal models. In this review, we provide insights from several forms of stress, including social defeat, chronic unpredictable stress, binge alcohol exposure, and disruptions in maternal care, implemented across different developmental epochs (either early postnatal, adolescent or adult) on neurobiological, circuit, and behavioral outcomes related to stress-associated pathology. Moreover, we highlight the synaptic changes associated with stress as well as new approaches and techniques for probing the impact of stress on circuit development, stability, and function. The results of these studies provide novel insights into the complex effects of stress on circuit development and function, how they may contribute to the multifaceted endophenotypes that when grouped together underlie disease susceptibility, and highlight novel pathways for the treatment of stress-related mental illnesses.

2. Impact of early life stress on the timing of neurobehavioral development -- Kevin Bath, Brown University {#sec2}
===========================================================================================================

Early life stress (ELS) significantly increases the risk for the later development of affective pathology, including depression and anxiety disorders. For example, a single significant stressor experienced during childhood increases the lifetime risk of anxiety or depressive pathology by ∼30% ([@bib4]). Importantly, as many as sixty-four percent of individuals will experience at least one significant stressor during childhood ([@bib4]). Having three or more adverse experiences early in life more than doubles the lifetime risk of developing affective pathology ([@bib4]), with females being nearly twice as likely as males to develop disorders ([@bib13], [@bib14], [@bib15], [@bib20], [@bib38], [@bib54], [@bib62], [@bib76], [@bib96], [@bib104], [@bib135], [@bib144], [@bib188]). The majority of these disorders are slow to develop with symptom expression increasing in late childhood and peaking during adolescence and early adulthood ([@bib171]), possibly implicating an atypical developmental process underlying the later emergence of pathology ([@bib20], [@bib181], [@bib192]). Despite such observations, most work to date has focused on either the proximate effects of stress on neuroanatomy, or outcome measures in adolescence and adulthood, with few studies assessing the effects of early adverse experience on developmental processes. A principle focus of this work was to assess the impact of stress on the timing of neural developmental events, and as an initial target we focused on the hippocampus, a region heavily implicated in stress-associated pathology.

2.1. Stress and the hippocampus {#sec2.1}
-------------------------------

In humans, depression and post-traumatic stress disorder have been associated with reductions in hippocampal volume ([@bib12], [@bib156], [@bib155], [@bib164]). In animal models, stress or the mimicking of HPA axis stimulation through chronic treatment with stress hormones can induce anxiety and depressive-like symptoms and drive regressive morphological changes of cells of the hippocampus, such as dendritic atrophy in CA1 and CA3 ([@bib117], [@bib121], [@bib186]) and the suppression of dentate gyrus neurogenesis ([@bib22], [@bib70], [@bib72], [@bib73], [@bib71]). The majority of those studies focus upon morphological changes in the adolescent or adult animal. However, ELS exposure has also been associated with: reduced cell proliferation and increased cell death in the dentate gyrus of the hippocampal formation of the perinatal rat ([@bib72], [@bib73], [@bib169]); simplification of dendritic arbors and enhanced dendritic turnover in CA1, CA3 and frontal regions ([@bib18], [@bib28], [@bib110]); decreased hippocampal synaptic density and reduced overall hippocampal volume when measured in adolescence and adulthood ([@bib5]) ([@bib58], [@bib170], [@bib180]). Thus, the hippocampus undergoes significant morphological changes in response to stress and represents an attractive target for understanding the impact of stress on developmental processes and for probing possible neurobiological substrates of pathological behavior.

2.2. Stress and development {#sec2.2}
---------------------------

In human studies and rodent models of ELS, adverse early experiences have been associated with somatic growth restriction and reductions in brain volume, including reduced hippocampus volume observed during adolescence and adulthood ([@bib58], [@bib170], [@bib180]). Exposure to chronic early adversity and adoption is associated with diminished stature and suppressed expression of growth hormone ([@bib132], [@bib174], [@bib175]). Previous work in rodents has identified suppressed neurogenesis in hippocampus following ELS or exposure to stress hormones ([@bib72], [@bib73], [@bib74], [@bib169]). Such observations have led to a prevailing view that ELS serves to suppress processes of growth at the somatic as well as neural level. Importantly, recent work has indicated that ELS may have activating effects on some aspects of somatic, hormonal, and behavioral development. In fact, it has been well documented that children exposed to chronic stress early in life show accelerated gonadal development, with females showing an earlier onset of menarche ([@bib1], [@bib34], [@bib55], [@bib93], [@bib125]), effects that have been mirrored in the sexual development of rodent models of poor maternal care ([@bib23], [@bib24]). In rodent models, ELS has also been associated with precocious development of defensive behaviors ([@bib167], [@bib168]), earlier development of fear associated learning ([@bib128], [@bib166]), and what appear to be more maturate forms of fear extinction in juvenile animals ([@bib21]). These effects appear to mirror earlier maturation of fear responding and functional connectivity in humans who experienced institutional rearing ([@bib64], [@bib63]). Taken together, these studies indicate that ELS, at least in some domains of somatic and neural function, may actually lead to accelerated maturation. Despite such observations, few studies have directly assessed the effects of ELS on the timing of maturation at the neural level. Here, we leverage a rodent model of ELS to test the hypothesis that stress serves to accelerate maturation of at least some regions of the brain, with a focus on the hippocampus.

2.3. Fragmented maternal care as a model of ELS {#sec2.3}
-----------------------------------------------

ELS was induced in a mouse model by disrupting maternal care through use of restricted access to bedding and nesting material from postnatal day 4 (P4) to postnatal day 11. In this paradigm, at P4 the dam and her litter were moved from standard housing to a cage with a wire mesh floor and ½ of a nestlet as their only source of nesting material. The limited access to nesting material leads to a fragmentation in maternal care ([@bib9], [@bib81], [@bib148]), with the dam leaving the nest more frequently than is observed under control housing conditions, and dams showing elevations in basal stress hormone levels during the period of restricted bedding. The dam and pups remain in these housing conditions for 7 days, until P11, and then are returned to standard housing conditions with full nesting. The combination of maternal stress and increased departures from the nest is associated with growth restriction in the pups, an effect that persists throughout early life ([@bib9], [@bib81], [@bib148]). Pups also show significant, but transient, elevations in basal stress hormone levels ([@bib9], [@bib148]), and disruptions in the expression of key regulatory elements of the HPA axis ([@bib9], [@bib148]). In the current studies, we collected tissue samples from the brains of control and ELS reared mice beginning prior to stress and sampling at regular intervals through early adulthood.

2.4. ELS and measures of neural maturation {#sec2.4}
------------------------------------------

In this model, we used a combination of BrdU pulse labeling as well as real-time quantitative polymerase chain reaction (RT-qPCR) to assess markers of cell proliferation and differentiation throughout early development. Consistent with previous reports using alternate forms of stress, or pharmacological stimulation of the stress axis, maternal bedding restriction was associated with an earlier decline in marker of cell proliferation, suggesting an earlier silencing of neurogenesis. To assess the effects of ELS on maturation of the hippocampus, we tested for effects of ELS on the developmental profile of three different neuromaturational events, synaptic maturation, interneuron development, and myelination ([@bib9]). At the synaptic level, previous work has shown a developmental shift in ratio of *N*-methyl-D-asparate (NMDA) receptor subunits NR2a and NR2b ([@bib157]). This shift occurs during the peri-adolescent period, with the expression of NR2a increasing relative to the NR2b subunit ([@bib113]). Using RT-qPCR on whole hippocampus, we could visualize the shift in subunit ratio, and found that this shift occurred a full week earlier in ELS reared mice ([@bib9]). During postnatal development, there is a significant increase in myelination throughout the brain. Using expression of myelin basic protein (MBP) as a marker for this process in the whole hippocampus, we observed a significant rise in MBP expression over the early postnatal period, with ELS animals showing a significant and earlier rise in MBP expression. Finally, we investigated the developmental expression of Parvalbumin (PV) in whole hippocampus, a calcium binding protein found on a subset of fast spiking interneurons. PV expression increases across early postnatal development, has been implicated in the opening and closure of sensitive periods, and has reliably been used as a marker of circuit maturation ([@bib8], [@bib25], [@bib68], [@bib88], [@bib90]). As with our other markers, we found an earlier expression of PV in the hippocampus of ELS mice relative to control reared animals, an effect that was confirmed by immunohistochemical detection of PV-protein in the dentate gyrus of the hippocampus ([@bib9]). We provide a graphical summary of these effects in [Fig. 1](#fig1){ref-type="fig"}.Fig. 1Impact of ELS on growth and maturation of the murine hippocampus. (A) Across early postnatal development there is a significant decline in rates of cell proliferation and differentiation. (B) Across this same period there is a gradual increase in makers of cellular and circuit maturation including myelination, synaptic differentiation, and interneuron integration. Across these measures, we find that ELS (dashed) leads to a more rapid silencing of neurogenesis and an earlier onset and completion of maturational processes in the hippocampus of the mouse.Fig. 1

2.5. ELS and cognitive and affective outcomes {#sec2.5}
---------------------------------------------

To test if the observed shift in gene expression, and histological markers of maturation were associated with changes in earlier behavioral development, we took advantage of a recently identified developmental decline in contextual freezing in a fear conditioning paradigm ([@bib139]). In that task, we found that ELS reared mice showed the anticipated decrease in freezing behavior, but that the decline in freezing occurred a full week earlier than was observed in control reared mice, occurring at P22 instead of P28. Together, our genetic, histological, and behavioral measures lead us to conclude that ELS drives an acceleration in the maturation of the hippocampus. To test if the accelerated maturation of this region was associated with the development of behavioral endophenotypes indicative of pathology, we carried out a battery of cognitive and affective tests in control and ELS reared mice. Interestingly, we found that female but not male mice reared under ELS conditions develop elevations in anxiety and depressive-like outcomes in early adulthood, while adult male but not female mice have impairments in spatial abilities ([@bib133]). In more recent work, both males and females were shown to have impaired performance on spatial learning at P21, however, the effects resolve in females by early adulthood but not in males (Bath et al. *in revision*). Thus, ELS leads to similar profiles in gross measures of accelerated hippocampus maturation in males and females, but different behavioral outcomes. Future studies will be critical to understand the contribution of changes in ontogenetic development to pathology and the unique consequences of ELS on the timing of neural development, sex differences in risk for select developmental events (e.g. neurogenesis, myelination), and the consequences of ELS on the development and connectivity between brain regions.

2.6. Conclusions and new research directions {#sec2.6}
--------------------------------------------

In summary, the studies presented here represent an initial demonstration that ELS in the form of disrupted maternal care, leads to an acceleration in hippocampus maturation at the behavioral and neural level. These findings reveal important effects of ELS on processes of growth and maturation and identify potential mechanisms through which stress might disrupt the timing of regional maturation, with implications for pathological development. The current studies support a framework in which ELS may drive an earlier maturation of at least some brain structures, potentially in the spirit of supporting earlier development in the face of an adverse early environment. In the context of an evolutionary framework, we interpret these findings to suggest that ELS may serve as an environmental signal of an inhospitable environment, recruiting earlier maturation of select structures of the brain to drive earlier development of centers supporting reproduction. This hypothesis is borne out of observations in humans and rodents showing that ELS accelerated the onset of cycling and expression of reproductive behaviors. However, such an interpretation is still highly speculative and will require significant additional data at the neural and behavioral level to support. If true, later emerging pathological outcomes could represent a negative byproduct of a shift in investment in regional brain development to support more proximate goals. Regardless, future studies investigating ELS effects on developmental processes will be required and may provide clues with regard to adaptive changes in circuit development in response to stress that may ultimately contribute to increased risk for pathological outcomes.

3. Plasticity of reward circuitry and stress disorders -- Scott Russo, Icahn School of Medicine at Mount Sinai {#sec3}
==============================================================================================================

The behavioral symptoms of depression are extensive, covering emotional, motivational, cognitive and physiological domains. Large subsets of patients with these disorders exhibit deficits in several aspects of reward. Prominent among these reward deficits is social avoidance and anhedonia, which are thought to result from major disruptions in reward circuit function. The best-characterized reward circuit in the brain is made up of dopaminergic neurons in the ventral tegmental area that project to the nucleus accumbens (NAc), a sub-division of the ventral striatum. The primary neuronal subtype within the NAc is the medium spiny neuron (MSN), which can be further sub-divided into dopamine receptor 1- (D1) and dopamine receptor 2- (D2) containing phenotypes. MSNs are crucial for recognition of rewarding versus aversive stimuli in the environment. The primary brain reward centers are inter-connected in complex ways. In addition to the dense dopaminergic input to the NAc, there is also dense glutamatergic innervation of NAc from the prefrontal cortex (PFC), ventral subiculum, amygdala, and intralaminar thalamus (ILT), among many other regions. Recent evidence suggests that distinct glutamatergic inputs may serve different roles in regulating reward and aversion ([@bib16], [@bib165]), which make them ideal candidates for modulation of stress and depression.

The NAc is an established stress-responsive brain region that undergoes remodeling of excitatory synapses following stress ([@bib149], [@bib150]). This remodeling is thought to alter synaptic connectivity within reward centers resulting in depression-like behavioral responses. To understand the role of such glutamatergic plasticity in stress-related disorders, we have recently employed a chronic social defeat stress (CSDS) model, consisting of repeated subordinations of an experimental C57BL/6 mouse by an aggressive CD-1 mouse. Social subordination stress is a well-established risk factor in the development of depressive and anxiety disorders ([@bib33]). As in humans, chronic social subordinations in mice leads to a spectrum of depression-like behaviors, such as social avoidance and anhedonia, in a subset of mice termed susceptible, whereas another subset of resilient mice resist the development of such behaviors ([@bib31]). Recent work demonstrates increased density of dendritic spines and excitatory postsynaptic currents on NAc MSNs following CSDS that correlates with social avoidance ([@bib30], [@bib69]). However, as mentioned above there are multiple glutamatergic inputs to NAc, which can uniquely control reward-related behavior ([@bib16], [@bib165]), and it is unclear from these studies whether there are unique presynaptic alterations of glutamatergic inputs to the NAc or whether there are adaptations on specific spines on MSNs in the NAc. Lastly, the role of these synaptic changes in mediating the effects of chronic stress on behavioral adaptations, such as anhedonia and social aversion are not well defined. Here we summarize evidence that CSDS changes synaptic transmission in a circuit, cell and spine type specific fashion in susceptible versus resilient mice. Our discussion will be focused exclusively on inputs to the NAc, however it is becoming clear that interactions between connections outside the NAc are important regulators of stress susceptibility ([@bib89], [@bib105]).

3.1. Glutamatergic stress circuits in the NAc {#sec3.1}
---------------------------------------------

Previous work has extensively characterized the effects of stress on synaptic plasticity at glutamate synapses throughout cortical hippocampal, striatal and amygdala regions ([@bib31], [@bib50], [@bib123], [@bib145]). These studies have largely found that while stress causes loss of dendritic spines and dendritic atrophy in the cortex and hippocampus, the NAc and amygdala undergo hypertrophy of dendrites and addition of dendritic spines. However, as mentioned above, these regions are highly interconnected and send direct projections to one another, which makes circuit based analysis crucial. Glutamatergic inputs to the NAc exhibit distinct molecular and electrophysiological properties thought to contribute to their differential roles in regulating striatal-dependent behaviors. For example, vesicular glutamate transporter 2 (VGLUT2) is enriched within ILT and ventral subiculum projecting neurons in the NAc, whereas vesicular glutamate transporter 1 (VGLUT1) is enriched in PFC projecting neurons in the NAc. Interestingly, Previous studies demonstrated distinct release properties of VGLUT1 versus VGLUT2 synapses as well as differential effects on postsynaptic responses of cholinergic interneurons in dorsal striatum ([@bib41]). In addition, previous work suggests that specific glutamate inputs play distinct roles in the expression of reward-related behavior ([@bib19], [@bib35], [@bib160], [@bib183]). Recently, using CSDS to model depression-like behaviors, it was shown that susceptible mice exhibit increased glutamatergic synaptic transmission within the ILT-NAc pathway measure by an increase in α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/NMDA currents whereas there was no effect on PFC-NAc pathway. A parallel study utilizing optogenetic stimulation to mimic long-term depression in the subiculum-NAc pathway found that enhanced transmission at subiculum synapses in the NAc also promoted susceptibility ([@bib6]). Together these data suggest that specific forms of plasticity at different glutamate inputs to NAc serve distinct functions in striatal transmission and differentially regulate depression-like behavioral responses following CSDS.

3.2. Stress-induced plasticity is cell and spine-type specific in NAc {#sec3.2}
---------------------------------------------------------------------

As mentioned above, stress increases the number of dendritic spines as well as glutamatergic transmission onto MSNs. However, the NAc contains both D1 and D2 MSNs, which play distinct roles in stress-induced depression-like behavior. A recent study by [@bib57] shows that CSDS increases synaptic transmission on D2 neurons of susceptible mice, while D1 neurons are more excitable in resilient mice. Using cell specific optogenetic techniques, they confirmed that activation of D1 neurons can promote resilience, while activation of D2 neurons promotes susceptibility. Thus, an important question remains whether there are any functional changes in the strength of excitatory signaling within D1 versus D2 MSNs at the level of single spines. Using two-photon preparations coupled to glutamate uncaging at single spines, we found that resilient mice exhibit increased unitary excitatory postsynaptic currents (uEPSCs) at mushroom spines on D1 neurons and decreased uEPSCs on D2 mushroom spines compared to control and susceptible mice. These results are in line with recent evidence that increased D1 activity is associated with resilience ([@bib101]). While we did not observe any significant changes in amplitude of uEPSCs in susceptible mice, these studies were performed at a holding potential of −70 mV, which only enables measurement of AMPA currents. Previously published work at the whole cell level suggests that the size or amplitude of AMPA currents do not differ between susceptible and control mice under these conditions ([@bib57]) and that synaptic adaptations in susceptible mice are reflected only in the frequency of synaptic events. Future studies will be needed to more clearly define synaptic transmission at NAc MSN spines in susceptible mice to determine whether alterations in transmission might also be caused by greater presynaptic release or greater frequency and amplitude of postsynaptic NMDA currents.

3.3. Sex differences in synaptic plasticity {#sec3.3}
-------------------------------------------

Much of the work discussed above has been performed in male mice only despite the fact that females often show distinct or more pronounced forms of plasticity within brain regions compared to males. For example, [@bib190] showed that chronic cocaine more robustly increases synaptic transmission and dendritic spine formation in female mice, which they suggest may also play a role in their enhanced behavioral response to cocaine. In our social stress studies, we have only recently been successful at adapting the social defeat model in C57BL/6 mice to females. Thus, we have relied more heavily on use of a subchronic variable stress (SCVS, consisting of 6 d of alternating stressors) protocol that selectively induces depression and anxiety-like behavior in female mice ([@bib84], [@bib106]). While males eventually succumb to chronic variable stress, they require up to 21 days to develop symptoms. Following SCVS, we find that females exhibit increases in the number of VGLUT2 positive similar to susceptible male mice in the social defeat model ([@bib83]). Importantly VGLUT2 does not change in resilient male mice following CSDS or SCVS. While these studies suggest that similar circuit mechanisms may drive depression-like behavior in both sexes, further work is needed to determine the specific circuits that undergo plasticity following stress as well as to test their functional role in regulating depression-like behavior.

3.4. Conclusions and new research directions {#sec3.4}
--------------------------------------------

Stress-induced synaptic plasticity within NAc microcircuitry is extremely complex. With the availability of new circuit specific tools described above we are gaining a level of precision and detail regarding cell types and circuits mediating stress-induced depression-like behavior not possible in earlier investigations of glutamate plasticity in stress phenotypes. In addition, by using circuit specific optogenetic approaches, we can now show directly whether changes in glutamate transmission can alter behavioral stress susceptibility. Furthermore, plasticity is occurring on both the macro (circuit) and micro (spine) level. The added precision and functional nature of two-photon glutamate uncaging studies on specific NAc MSN subtypes have allowed us to identify altered excitatory synaptic responses within resilient mice that may reflect an active, adaptive coping response to limit stress experience. Thus, it seems likely that there is a change in the postsynaptic machinery within D1 versus D2 neurons that alters synaptic strength---a hypothesis that we can now test.

Despite much progress, future work into the circuit basis of depression is clearly needed. For example, much of the work so far has focused on single monosynaptic inputs to the NAc. We know that these brain regions are connected in complex ways and a systems level analysis may help us to better understand how these brain regions are working together to control depression-like behavior. Furthermore, in vivo tools to measure neural activity are becoming increasingly accessible. It is now possible to perform multi-structure analysis of specific cell types and circuits utilizing photometric calcium imaging or single unit opto-tagging to measure changes in neural activity longitudinally during the course of stress exposure. The importance of such longitudinal analysis is that we may be able to identify patterns of activity that predict susceptibility or resilience to stress. Ultimately, we need to confirm results from rodent studies in human patients using state-of-art non-invasive imaging tools so that we can build a relevant circuit map of depression and antidepressant treatment responses.

4. Stressing thalamo-limbic circuits with repeated drinking -- Kristen Pleil, Weill Cornell Medical College {#sec4}
===========================================================================================================

Excessive alcohol consumption is a leading cause of preventable death and disease burden, costing the U.S. government an estimated \$249 billion per year. It leads to increased risk for many chronic negative health conditions, including cancers, cardiovascular disease, diabetes, and neuropsychiatric diseases such as alcohol dependence and mood disorders ([@bib53], [@bib65], [@bib177]). Epidemiologic research shows that the two most important factors determining the negative health impact of alcohol use are the cumulative volume consumed and the pattern of this consumption over one\'s lifetime. In particular, a repetitive, cyclic pattern of binge alcohol drinking to intoxication, defined as acutely reaching a blood ethanol content (BEC) of at least 80 mg/dl, and withdrawal is hypothesized to contribute to alcohol dependence by causing aberrant adaptations in brain regions that underlie stress responses and reward-seeking, leading to a state of anxiety or negative affect that drives subsequent drinking ([@bib11], [@bib102], [@bib103], [@bib159]). As such, individuals with an alcohol use disorder are at a substantially increased risk for having a comorbid mood disorder such as anxiety or depression, but the underlying mechanisms of these diseases remain elusive and current pharmacotherapies are fairly ineffective at treating people without causing devastating off-target effects. We have focused our research efforts on identifying the brain circuits that drive binge drinking behavior and the crucial molecular mechanisms of neuropeptides that tune plasticity within those circuits, as these may be essential to finding effective targets for the treatment for alcoholism and mood disorders.

4.1. Mouse models of binge alcohol drinking {#sec4.1}
-------------------------------------------

Many studies over the past several decades have used dependence-inducing models of chronic alcohol exposure in rodents to characterize adaptations in neural circuitry, neuronal activity, and molecular signaling in alcohol dependence. More recently, a focus has been placed on identifying the key adaptations that occur during repeated binge drinking prior to the development of alcohol addiction and/or mood disorders that might precipitate their emergence or trigger other neuroadaptations that maintain disease states. Specifically, these paradigms use limited or intermittent access to alcohol within or across days in order to produce binge-like alcohol drinking to intoxication upon each exposure, which is followed by withdrawal when alcohol access is removed. Repeated cycles of this "roller coaster" of BEC closely model human binge drinking behavior ([@bib147], [@bib172]) and capitalize on the epidemiological evidence that large volume, cyclic alcohol intake maximizes the potential negative behavioral and health effects of alcohol consumption.

A model that is now standard in our lab and others' is the Drinking in the Dark (DID) model of binge drinking ([@bib142], [@bib172], [@bib173]). In this paradigm, mice are given access to 20% alcohol for 2 h, beginning 3 h into the dark phase of the light-dark cycle, for three consecutive days, followed by 4 h of access on the fourth day. Mice binge drink to intoxication, particularly on the fourth day, achieving high BEC levels (≥80 mg/dl) ([@bib142], [@bib147]) prior to withdrawal when alcohol access is removed. As few as three cycles of DID with three-day protracted abstinence periods between cycles lead to long-lasting increases in subsequent voluntary alcohol consumption prior to the development of alcohol dependence ([@bib36]). We and others have used this paradigm to identify key neural circuits and neuropeptide signaling mechanisms involved in binge drinking, determine at what point(s) during chronic alcohol exposure these mechanisms begin to diverge from a "normal" pattern, and evaluate whether these changes persist into alcohol dependence and chronic anxiety states ([@bib114], [@bib115], [@bib140], [@bib141], [@bib142]). These may be key changes that occur early on during exposure to confer increased risk for the development of neuropsychiatric disease, providing especially useful targets for prevention and treatment.

4.2. The roles of extrahypothalamic corticotropin-releasing factor (CRF) and neuropeptide Y (NPY) in binge drinking {#sec4.2}
-------------------------------------------------------------------------------------------------------------------

Endogenous "stress" and "anti-stress" neuropeptide systems have long been described to play important opposing roles in many behaviors and physiological functions, including alcohol drinking and anxiety behavior, via signaling at their G protein-coupled receptors (GPCRs) located throughout the brain. In particular, the stress neuropeptide CRF and the anti-stress NPY produce divergent behavioral phenotypes, and peptide levels and polymorphisms in the genes coding both of these peptides and their receptors are associated with alcohol drinking behavior, stress responsivity, and the susceptibility to the development of alcohol addiction and anxiety states in humans, monkeys, and rodents ([@bib7], [@bib77], [@bib78], [@bib79], [@bib80], [@bib109], [@bib129], [@bib154], [@bib195]). Both peptides are recruited during binge alcohol drinking and altered in rodent models of alcohol dependence ([@bib59], [@bib79], [@bib80], [@bib115], [@bib197]), and a large literature indicates that pharmacological or genetic manipulations of CRF, NPY, and their receptors alters the stress/anxiety response and plays a role in alcohol drinking and addiction ([@bib67], [@bib78], [@bib87], [@bib114], [@bib197]). Systemic or central administration of CRF and CRF1 receptor agonists enhance alcohol consumption, while CRF1 receptor antagonists blunt high levels of drinking in DID and other voluntary consumption paradigms without altering low, non-binge levels of alcohol consumption ([@bib32], [@bib114], [@bib136], [@bib163], [@bib176]). Expression of CRF and its receptors are altered in limbic and cortical brain regions during binge alcohol drinking, chronic alcohol exposure, and withdrawal ([@bib87], [@bib138], [@bib199]), suggesting that plasticity upregulating central extra-hypothalamic CRF systems may contribute to increased alcohol consumption during the development of alcohol dependence ([@bib107]). In contrast, the anti-stress neuropeptide Y (NPY) system blunts excessive alcohol consumption and produces anxiolysis, predominantly via activation of NPY receptor 1 (Y1R) ([@bib39], [@bib162]). It is believed that NPY activation during alcohol or stress exposure serves to maintain or re-achieve homeostasis via direct or indirect functional interactions with the CRF system ([@bib95], [@bib152]), however the site and nature of the interaction between these systems is poorly understood. And, repeated binge drinking may disrupt the typical balance between the signaling or function of these peptide systems, leading to an increasingly dysregulated response over alcohol/stress exposures that perpetuate a trajectory toward neuropsychiatric disease.

4.3. The bed nuclei of the stria terminalis (BNST) as a site for peptide-peptide interactions {#sec4.3}
---------------------------------------------------------------------------------------------

The BNST is a limbic structure enriched with neuropeptides including CRF and NPY that receives dense synaptic input from several cortical, limbic, thalamic, and hindbrain structures and projects to many brain areas directly involved in the regulation of anxiety and alcohol/drug-related behaviors ([@bib42], [@bib43], [@bib44], [@bib52], [@bib66], [@bib118]). As a limbic "hub" within the extended amygdala, it is a site of integration of stress and reward information ([@bib26], [@bib29], [@bib119], [@bib124], [@bib182]) and anatomically situated to mediate the negative affective state associated with chronic alcohol use ([@bib102], [@bib103]). Previous research has shown that the BNST mediates stress responsivity and stress-induced relapse to drug seeking, potentially via CRF-dependent mechanisms ([@bib52], [@bib151], [@bib184]). Pharmacological manipulations of CRF or NPY in the BNST can alter alcohol-drinking behaviors and chronic alcohol exposure and withdrawal alter the function and synaptic plasticity of BNST neurons, including CRF neurons ([@bib56], [@bib158]).

We recently provided the first evidence that the central NPY and CRF systems interact directly to modulate binge alcohol drinking behavior, and that long-lasting plasticity in this interaction occurs with as few as three cycles of DID binge drinking ([@bib142]). We showed that CRF neurons in the BNST drive binge alcohol drinking behavior and anxiety in mice. NPY signaling in the BNST blunts binge drinking by activating postsynaptic G~i~-coupled Y1Rs located specifically on CRF neurons, increasing the trafficking/surface expression of gamma-aminobutyric acid type A (GABA~A~) receptors to the postsynaptic membrane through a protein kinase A-dependent mechanism and leading to greater synaptic inhibition of CRF neurons. We hypothesized that this mechanism of NPY would be down/dysregulated after three cycles of DID, providing a functional mechanism for the escalation of alcohol consumption and preference that has been shown to emerge at this time point. However, we surprisingly found that this Y1R-mediated synaptic effect and Y1R protein expression were upregulated, providing increased homeostatic inhibition of CRF neurons, for at least ten days following the last binge drinking episode. We also found this same synaptic upregulation of Y1R in alcohol-dependent rhesus monkeys using a chronic voluntary alcohol drinking paradigm, suggesting that this adaptation occurs across mammalian species and states of alcohol dependence. Therefore, this appears to be a critical node of circuitry that undergoes plasticity that is initiated across binge drinking episodes and sustained into the development of dependence. This finding has led us to question whether there is an upregulation of excitatory synaptic transmission at BNST CRF neurons that necessitates increased Y1R-mediated inhibition as a protective mechanism.

4.4. Thalamo-limbic drive of binge drinking behavior {#sec4.4}
----------------------------------------------------

The excitatory neurotransmitter glutamate promotes alcohol drinking and plays an important role in alcohol dependence. For example, systemically-administered glutamate receptor antagonists reduce binge alcohol consumption during DID ([@bib75]) and are used to block relapsed drinking behavior in alcoholics ([@bib10]). There is evidence that the site of some of these glutamate-dependent effects may be via modulation of BNST CRF neurons, as chronic alcohol exposure alters synaptic modulation of CRF neurons and produces CRF-dependent alterations in the intrinsic excitability of some BNST neurons ([@bib56], [@bib158]). Therefore, we have recently begun identifying and characterizing what excitatory inputs to BNST CRF neurons may provide feed-forward modulation of their activity to promote binge drinking behavior.

Preliminary anatomical mapping studies using retrograde and anterograde tracers have identified many previously identified and several novel glutamatergic (VGLUT2-positive) inputs to the BNST, including the paraventricular nucleus of the thalamus (PVT) ([@bib131]). Like the BNST, the PVT is implicated in compulsive drug/alcohol seeking, anxiety and negative affect, and reinstatement of drug and alcohol seeking ([@bib91], [@bib198]). Given its glutamatergic connectivity with the BNST and involvement in reward-seeking and anxiety, we hypothesize that it may be involved in the regulation of binge drinking via excitatory drive onto CRF neurons in the BNST. Preliminary evidence using chemogenetic manipulation of PVT VGLUT2 neurons suggests that these neurons drive binge-drinking behavior, and ongoing studies are evaluating whether they do so via their projection to the BNST. In addition, slice electrophysiology experiments show that PVT glutamate neurons provide direct, monosynaptic excitatory input to CRF neurons in the BNST. We are currently examining the plasticity in PVT glutamate neurons, BNST CRF neurons, and the synaptic connections between them across binge drinking episodes.

4.5. Conclusions and new research directions {#sec4.5}
--------------------------------------------

While we are making progress toward understanding broader circuit context and signaling mechanisms of BNST CRF neuron drive of binge drinking behavior, the PVT is just one of many glutamatergic inputs and NPY just one of many neuropeptides that may highly regulate the function of BNST CRF neurons. There are also many other known brain regions, neural pathways, and molecules involved in the regulation of binge alcohol drinking and stress responsivity that we and others are actively characterizing. We are currently examining how gonadal and stress hormones modulate these known and newly identified circuits and peptidergic mechanisms in a sex-dependent fashion. The rate of binge drinking is increasing across the U.S., and at a particularly alarming rate in women, who are more susceptible to developing comorbid expression of alcohol dependence and mood disorders. However, females have been underrepresented or excluded from much of the pre-clinical and clinical research for the development of pharmacological treatments. We believe that acute hormone signaling dynamically regulates peptide and circuit function to modulate these behaviors and confers increased susceptibility to neuropsychiatric disease in females, and that understanding these modulatory processes will lead to better treatment strategies.

5. Disruption of mTORC1 signaling contributes to synaptic deficits caused by chronic stress: reversal by rapid-acting antidepressants - Eric Wohleb and Ronald Duman, Yale University {#sec5}
=====================================================================================================================================================================================

The precise molecular and cellular mechanisms underlying symptoms of major depressive disorder (MDD) remain unclear, but considerable headway has been made in understanding the neurobiology of depressive-like behaviors in rodent models. Clinical and preclinical studies indicate that behavioral symptoms of MDD stem from neurobiological alterations that include dendritic atrophy and synaptic loss on pyramidal neurons in the PFC as well as the hippocampus. In preclinical models of MDD these neuroplasticity deficits can be provoked by psychosocial and environmental stressors, which include repeated exposure to social defeat, restraint, or chronic unpredictable stress ([@bib31], [@bib49], [@bib50]). Indeed seminal work shows that repeated exposure to stressors reduced dendritic complexity of pyramidal neurons in the medial PFC, which leads to impaired regulation of emotion and cognition ([@bib116], [@bib143], [@bib146]). Of note, these findings in rodent models recapitulate clinical findings as long-term psychosocial stress in humans is shown to similarly disrupt cortical connectivity and promote attentional control impairments ([@bib112], [@bib111]).

While it is evident that stress-induced neuronal atrophy in corticolimbic brain regions contributes to the neurobiology of depressive-like behavior, the molecular mechanisms underlying these processes remain poorly understood. The mechanistic target of rapamycin complex 1 (mTORC1) pathway is a critical regulator of protein synthesis-dependent synaptic plasticity and formation of new synapses. Thus, inhibition of this pathway could contribute to the atrophy of neurons seen in corticolimbic brain regions in depressed patients and rodent stress models. In support of this possibility, a postmortem study showed that protein levels of mTOR as well as a downstream mediator p70 ribosomal protein S6-kinase (p70S6K) were reduced in the PFC of depressed subjects ([@bib92]). Consistent with these findings, initial studies in our laboratory revealed that chronic unpredictable stress exposure (CUS) for 3 weeks decreased mTORC1-p70S6K signaling in the PFC ([Fig. 1](#fig1){ref-type="fig"}).

5.1. Stress-induced up-regulation of REDD1 drives synaptic deficits and depressive-like behaviors via decreased mTORC1-p70S6K signaling {#sec5.1}
---------------------------------------------------------------------------------------------------------------------------------------

To further examine the role of mTORC1-p70S6K signaling, studies were conducted to test the hypothesis that stress caused neuronal atrophy and synaptic deficits by modulating this signaling pathway. The up-stream negative regulator of mTORC1, referred to as REDD1 (regulated in development and DNA damage responses 1), was identified as a candidate because REDD1 is induced by glucocorticoids and activation of the hypothalamic-pituitary-adrenal axis, a hallmark neuroendocrine target of stress. Indeed, our studies demonstrated that CUS exposure increased levels of REDD1 mRNA and protein in the PFC ([@bib137]). In addition, postmortem gene expression analyses showed that REDD1 was elevated in the dorsolateral PFC of depressed individuals. Further viral-mediated over-expression of REDD1 in the rat medial PFC was sufficient to decrease the phosphorylated and activated forms of mTORC and p70S6K and caused depressive-like behaviors. Moreover, DiOlistic labeling of pyramidal neurons in the medial PFC showed that REDD1 over-expression significantly decreased synaptic spine density on apical dendrites ([Fig. 2](#fig2){ref-type="fig"}). In contrast, mice lacking REDD1 expression were resilient to CUS-induced depressive-like behavior, as well as decreased mTORC1-p70S6K signaling and the synaptic deficits in the medial PFC caused by chronic stress exposure. These findings indicate that stress-induced REDD1 expression leads to decreased mTORC1-dependent signaling, synaptic deficits in the medial PFC, and development of depressive-like behaviors ([@bib137]). This is the first direct evidence that mTORC1 signaling plays an important role in mediating the synaptic and behavioral deficits associated with chronic stress and MDD ([Fig. 2](#fig2){ref-type="fig"}).Fig. 2mTORC1-p70S6 kinase signaling in synaptic plasticity effects of stress and rapid antidepressant actions. In rodents exposed to stress and patients with MDD, REDD1 expression is increased leading to reduced mTORC1-p70S6 kinase signaling and decreased synapse number and function. Viral-mediated overexpression of REDD1 or dominant negative forms of p70S6 kinase cause similar neuronal and behavioral effects. In contrast, treatment with ketamine or scopolamine causes glutamate influx in the PFC promoting AMPA receptor activation, which increased mTORC1-p70S6K signaling, contributing to increased synaptic plasticity underlying antidepressant responses. Similar antidepressant responses can be attained with viral-mediated expression of constitutively active forms of p70S6 kinase.Fig. 2

To further examine the role of mTORC1 signaling in the neurobiology of MDD and antidepressant treatment, studies were conducted to determine the influence of increasing or decreasing the functional activity of p70S6K ([@bib51]). These studies were directed by previous work that showed rapid-acting antidepressants promote synaptic plasticity through activation of mTORC1 signaling ([@bib108], [@bib178]). In order to examine the role of downstream p70S6K in antidepressant behavioral effects, viral constructs were designed with either constitutively active or dominant negative forms of p70S6K, which allowed for broad control of translational pathways. As expected cell culture experiments showed that the constitutively active p70S6K increased overall protein translation, while the dominant negative p70S6K limited protein production ([@bib51]) ([Fig. 2](#fig2){ref-type="fig"}). Infusion of the constitutively active p70S6K in the medial PFC of rats produced antidepressant-like effects and prevented stress-induced anhedonia. In contrast, rats that received the dominant negative form of p70S6K showed depressive-like behaviors and ketamine failed to produce an antidepressant response under these conditions of p70S6K blockade ([@bib51]). These findings demonstrate that manipulations in p70S6K activity modulate depressive-like behavioral states and further reinforce the role of mTORC1-p70S6K signaling in the pathophysiology and treatment of MDD. In the end, our results support development of molecules that inhibit REDD1 or activate mTORC1-p70S6K signaling as novel therapeutic targets for the treatment of depression ([Fig. 2](#fig2){ref-type="fig"}).

5.2. GABA interneurons in the prefrontal cortex are critical mediators of rapid-acting antidepressants {#sec5.2}
------------------------------------------------------------------------------------------------------

The development of more effective pharmacological therapies for MDD is important as the therapeutic efficacy of clinical treatments are limited, and some patients develop treatment-resistance, failing to respond to two or more different antidepressant agents ([@bib161]). The discovery of rapid-acting antidepressant drugs, including scopolamine, a nonselective muscarinic acetylcholine receptor (mAChR) antagonist, and ketamine, an NMDA receptor antagonist have had a dramatic effect on the antidepressant treatment field ([@bib46], [@bib50]). Preclinical research indicates that scopolamine and ketamine induce rapid antidepressant responses through glutamate release, neuronal activity-dependent mTORC1 signaling and increased synaptic plasticity in the medial PFC ([@bib108], [@bib134], [@bib178]). The converging physiological and molecular pathways utilized by ketamine and scopolamine suggest that microcircuitry in the medial PFC is engaged to initiate glutamate release and subsequent downstream mTORC1 signaling ([@bib127], [@bib194]). In particular, ketamine and scopolamine may promote glutamate release by antagonism of inhibitory interneurons, thereby disinhibiting pyramidal neurons in the medial PFC ([@bib85], [@bib126], [@bib194]) ([Fig. 3](#fig3){ref-type="fig"}). Further recent reports indicate that specific neurotransmitter receptor subtypes mediate these neuronal and behavioral effects; in particular the M1-type AChR mediates, at least in part, the effects of scopolamine ([@bib134], [@bib178], [@bib191]). Through Cre-dependent conditional knockdown of M1-AChR we showed that scopolamine engaged GABA interneurons in the medial PFC to initiate antidepressant responses. Further studies revealed that M1-AChR expression on somatostatin interneurons in the medial PFC are required for the antidepressant-like effects of scopolamine ([@bib194]). In the end, these studies provided evidence that scopolamine antagonism of PFC interneurons provides the initial cellular trigger leading to glutamate release and subsequent activity-dependent mTORC1 signaling underlying rapid antidepressant responses ([Fig. 3](#fig3){ref-type="fig"}). Similar studies are currently being conducted to examine the cellular trigger for ketamine, and if this also includes disinhibition of glutamate transmission via blockade of NMDA receptors on GABAergic neurons in the medial PFC.Fig. 3GABA interneurons in the medial PFC mediate antidepressant effects of ketamine and scopolamine. GABA interneurons in the medial PFC tonically inhibit excitatory pyramidal neurons (Δ). Rapid antidepressant drugs antagonize GABA interneurons (somatostatin (SST); parvalbumin (PV)), leading to disinhibition of pyramidal neurons and subsequent stimulation of neuronal activity-dependent molecular pathways in pyramidal neurons that underlie behavioral responses to ketamine and scopolamine.Fig. 3

5.3. Potential sex differences in stress-induced neuronal atrophy in the medial prefrontal cortex and responses to rapid-acting antidepressants {#sec5.3}
-----------------------------------------------------------------------------------------------------------------------------------------------

While the majority of studies performed in the lab have used males, it is important to consider sex-dependent differences in responses to stress and antidepressant treatment. Indeed varied neurobiology and neuroendocrine responses in males and females likely contribute to disproportionate prevalence of affective disorders in females ([@bib97], [@bib100]). Interestingly, rodent models indicate that estrogen signaling prevents repeated restraint-induced synaptic deficits in the medial PFC, preventing cognitive deficits ([@bib187], [@bib196]). This is consistent with studies showing that repeated stress exposure does not cause pyramidal neuron atrophy in the medial PFC of females; in fact pyramidal neurons projecting to basolateral amygdala appear to increase dendritic complexity ([@bib61], [@bib153]). Further research into the specific neurocircuitry influenced by stress exposure will lend insight into the pathophysiology leading to differences in susceptibility to affective disorders.

Sex-dependent differences in neurobiology are also implicated in the response to rapid-acting antidepressants, particularly scopolamine ([@bib193]). Clinical studies comparing males and females treated with scopolamine revealed that females have larger antidepressant and anxiolytic responses ([@bib60]). It is important to point out there is no indication that antidepressant responses to ketamine differ between males and females. In either case these findings warrant further research into potential sex-dependent differences in the neurocircuitry and molecular mechanisms mediating rapid antidepressant responses.

5.4. Conclusions and future research directions {#sec5.4}
-----------------------------------------------

Altogether studies reviewed here support the notion that disruption of mTORC1-p70S6K signaling leads to stress-induced synaptic deficits and contributes to development of depressive-like behaviors. Indeed viral-mediated techniques to promote mTORC1-p70S6K signaling lead to enhanced synaptic plasticity and prevent depressive-like behaviors. These studies are consistent with preclinical studies showing rapid-acting antidepressants engage mTORC1-p70S6K signaling to reverse stress-induced synaptic deficits on pyramidal neurons. Recent studies aimed to uncover the PFC microcircuitry that triggers activity-dependent mTORC1-p70S6K signaling revealed a critical role of GABA interneurons. Further research into the microcircuitry of the medial PFC and specific receptor expression in interneuron subtypes targeted by rapid-acting antidepressants will undoubtedly uncover innovative pharmacological pathways for the treatment of affective disorders.

6. General summary {#sec6}
==================

The work presented in this symposium highlights several themes for understanding the neurobiological changes associated with repeated exposure to salient environmental stimuli. An important idea from each perspective is that protracted challenges have the capacity to alter subsequent behavioral response strategies. On the one hand, responses to chronic stress are considered to be adaptive from an ecological standpoint, regardless of individual variations and/or their implications for altering the developmental trajectory. Nevertheless, many of the adaptations to repeated stress highlighted in each presentation increase vulnerability to stress-related psychiatric disorders. Thus, adaptation appears to come with associated costs, and/or depends on the context under which adaptation is defined (i.e., for survival vis-à-vis increased disease risk). Moreover, each presentation highlights aspects of core circuitry that provides a substrate for stress-induced synaptic and cellular alterations. Dr. Pleil\'s presentation provides mechanistic insight regarding the synaptic changes in "stress" pathways involving BNST CRF neurons that drive binge drinking behavior. Dr. Russo\'s work directs attention to differential circuit and synaptic perturbations within and involving the NAc as a function of stress endophenotype that lay some of the groundwork for mapping the circuits and mechanisms of altered hedonic response as part of depression-like behaviors. Drs. Wohleb and Duman have significantly advanced understanding of the cellular mechanisms underlying chronic stress-induced regressive structural and functional plasticity in the prefrontal cortex, and have made inroads into understanding how novel therapeutic approaches may intercede on signaling events to reverse these alterations. Dr. Bath\'s work raises the novel hypothesis that early-life stress may accelerate regional brain maturation and precocious expression of corresponding behaviors. From an adaptive perspective, stress effects on the timing of neurodevelopmental events may support a bias toward earlier maturation of structures supporting emotional responding, self-preservation, and reproductive development. If accelerated maturation is restricted to select regions of the brain, the mismatch in timing of regional development could contribute to increased susceptibility for pathological behavior.

While these limbic and related structures have long since been appreciated to be involved in stress-related pathologies, these sets of studies highlight novel and integrative perspectives that have advanced understanding how these loci interact to produce stress-related alterations at the circuit and behavioral level, and also provide a clear mechanistic basis for how these circuits function in resilient and susceptible endophenotypes, whether naturally occurring or provoked by early-life experiences. Finally, their implementation with studies directed toward describing how these circuits and mechanisms are altered by antidepressant treatments have provided additional insight into innovative pathways for the treatment of stress-related mental health disorders.
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